Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInsig Ai Plc Regulatory News (INSG)

Share Price Information for Insig Ai Plc (INSG)

Share Price is delayed by 15 minutes
Get Live Data
13.50    -0.50 (-3.57%)
Bid:
13.00
Ask:
14.00
Spread: 1.00 (7.692%)
Market Cap: £17.22m
INSG Live PriceLast checked at - London Stock Exchange

Intraday Insig Ai Plc Share Chart

Trading Update and New Client Win

29 Apr 2025 07:00

RNS Number : 5183G
Insig AI Plc
29 April 2025
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

29 April 2025

Insig AI plc

("Insig AI", the "Company" or the "Group")

Trading update for the year ended 31 March 2025 and new client win

 

Trading ahead of expectations

Insig AI plc (AIM:INSG), the data science and machine learning solutions company, is pleased to announce that trading for the fourth quarter and for the year to 31 March 2025 has been ahead of previous management guidance. Revenue for the fourth quarter was £249k, equivalent to 90% higher than the third quarter and 210% higher than the second quarter. The fourth quarter outturn was 11.2% above expectations announced on 24 March 2025.

New client win and orders

The Company is pleased to announce that it has also secured a new client win from a London-based, European focused asset manager with assets under management of more than £1 billion. The client specialises in distressed corporate and asset-backed investments. The work won relates to the automation of data collection and ingestion and comprises both a licence fee and an ongoing annual retainer. Whilst the initial works are not material from a revenue perspective, management believes this win can lead to significant additional work from this client in the current year.

The Company has also received confirmation from another new prospect, which although still subject to final documentation, is from a London based asset manager with assets under management of more than £1 billion, specialising in a global equities. Its focus is on using Insig AI to improve its automation of data collection.

Earlier this month, the Company announced that it received a purchase order from the Financial Conduct Authority for a subscription service licence agreement to access Insig AI's Transparency and Disclosure Index ("TDI") covering UK listed companies.

Richard Bernstein, Insig AI's Chief Executive commented: "We are pleased that the outturn for the year to March 2025 has been better than our expectations and delighted that the current year has gotten off to the best possible start. Our new sales strategy, which we announced last December, is now bearing fruit. Our clearly defined offerings are resonating well with prospects. We are also making exciting progress developing new automation tools that leverage our machine-learning and AI capabilities, which we are planning to be able to apply to other verticals."

 

For further information, please visit www.insig-ai.com or contact: 

Insig AI plc

 

Richard Bernstein, CEO

richard.bernstein@insg.ai

Zeus (Nominated Adviser & Broker)

David Foreman / James Hornigold

+44 (0) 203 829 5000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBVLLLEZLEBBD
Date   Source Headline
6th Sep 20247:00 amRNSDirector/PDMR Dealing
1st Aug 20247:00 amRNSDirector/PDMR Dealing
3rd Jul 20247:00 amRNSConvertible Loan Notes
21st Jun 20242:30 pmRNSHolding(s) in Company
10th Jun 202411:36 amRNSHolding(s) in Company
6th Jun 20247:00 amRNSGrant of options
5th Jun 20247:00 amRNSEquity Subscription and TVR
30th May 20246:28 pmRNSDirector/PDMR Dealing
30th May 20247:02 amRNSShare subscription, director dealing and TVR
30th May 20247:01 amRNSStrategic investment, revenue share and TVR
30th May 20247:00 amRNSBoard changes
2nd May 20247:00 amRNSShare subscription, director dealing and TVR
17th Apr 20247:00 amRNSDirector/PDMR Shareholding
4th Apr 20247:00 amRNSFunding facility, share allotment & PDMR dealing
2nd Apr 20247:00 amRNSTrading update & equity funding facility proposal
28th Dec 20237:00 amRNSInclusion within UN Environment Programme Tool
22nd Dec 20237:00 amRNSDirector/PDMR Shareholding
21st Dec 20237:00 amRNSDirector/PDMR Shareholding
20th Dec 20237:00 amRNSInterim results
28th Nov 20237:00 amRNSAppointment of investor relations adviser and TVR
27th Nov 20237:00 amRNSCorporate development adviser and TVR
15th Nov 20237:00 amRNSDisposal, Loan Conversion, New Project Win & TVR
30th Oct 20237:00 amRNSNew Product Launch
28th Sep 20237:00 amRNSAppointment of Strategic Adviser and TVR
15th Sep 20233:56 pmRNSResult of AGM
15th Sep 20237:00 amRNSAGM Statement
30th Aug 20237:00 amRNSDirector/PDMR Shareholding
24th Aug 20237:00 amRNSDirector/PDMR Shareholding
21st Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
14th Aug 20237:00 amRNSFinal Results, Posting of Report and Notice of AGM
1st Aug 20234:42 pmRNSChange of Registered Office
31st Jul 20235:30 pmRNSTotal Voting Rights
4th Jul 20237:00 amRNSRevision of Convertible Loan Facility Agreement
19th May 20237:00 amRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
25th Apr 20237:00 amRNSDeath of Director
24th Apr 20237:02 amRNSEquity subscription
24th Apr 20237:01 amRNSInsig AI Data & Technology Collaboration with FCA
24th Apr 20237:00 amRNSTrading and operations update
9th Mar 20237:00 amRNSInsig AI showcase Generative AI Product Capability
6th Feb 20237:00 amRNSGenerative AI Product Capability
16th Jan 20237:00 amRNSDirector/PDMR Shareholding
9th Jan 20237:00 amRNSConvertible Loan Facility Drawdown
28th Dec 20227:00 amRNSDirector/PDMR Shareholding
23rd Dec 20227:00 amRNSDirector Dealing
22nd Dec 20227:00 amRNSRevision of Convertible Loan Facility Agreements
21st Dec 20227:00 amRNSDirectors gift shares to Company treasury & TVR
19th Dec 20227:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.